| Not Yet Recruiting | A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Mon RSV Infection, RSV, Respiratory Syncytial Virus (RSV) | Phase 2 | 2026-07-01 |
| Completed | A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy RSV Infection, Drug Drug Interaction | Phase 1 | 2025-03-13 |
| Completed | A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazol RSV Infection, Drug Drug Interaction (DDI) | Phase 1 | 2025-01-27 |
| Completed | A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults RSV Infection, QTc Interval | Phase 1 | 2024-07-15 |
| Completed | A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection RSV Infection | Phase 2 | 2023-11-20 |
| Completed | A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. RSV Infection | Phase 2 | 2022-11-29 |
| Completed | A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 COVID-19 | Phase 2 | 2022-11-10 |
| Completed | Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects COVID-19 | Phase 1 | 2022-10-06 |
| Completed | Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects. COVID-19 | Phase 1 | 2022-10-06 |
| Completed | A Study of EDP-323 in Healthy Subjects RSV Infection | Phase 1 | 2022-09-29 |
| Completed | A Study to Evaluate EDP 938 Regimens in Children With RSV Respiratory Syncytial Virus (RSV) | Phase 2 | 2022-04-26 |
| Completed | A Study of EDP-235 in Healthy Subjects SARS CoV 2 Infection | Phase 1 | 2022-01-28 |
| Terminated | A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH Chronic Hepatitis B Virus Infection | Phase 1 | 2021-08-02 |
| Terminated | Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of th Respiratory Syncytial Virus Infections | Phase 2 | 2021-07-07 |
| Completed | Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects Respiratory Syncytial Virus (RSV) | Phase 1 | 2021-05-28 |
| Completed | Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects RSV Infection | Phase 1 | 2021-03-12 |
| Completed | Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects Hepatitis B | Phase 1 | 2020-11-05 |
| Completed | A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment Chronic HBV Infection | Phase 1 | 2020-09-09 |
| Completed | A Study of EDP-297 in Healthy Subjects NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis | Phase 1 | 2020-09-08 |
| Completed | Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Sub RSV Infection | Phase 1 | 2020-07-08 |
| Terminated | A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Pr Non-Alcoholic Steatohepatitis | Phase 2 | 2020-01-27 |
| Completed | A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncyt Respiratory Syncytial Virus | Phase 2 | 2020-01-22 |
| Completed | A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) Chronic HBV Infection | Phase 1 | 2019-06-26 |
| Completed | Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects RSV Infection | Phase 1 | 2018-11-29 |
| Completed | A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined NASH - Nonalcoholic Steatohepatitis | Phase 1 | 2018-11-27 |
| Completed | Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects RSV Infection | Phase 1 | 2018-11-02 |
| Completed | A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model RSV Infection | Phase 2 | 2018-10-15 |
| Completed | Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects NASH - Nonalcoholic Steatohepatitis | Phase 1 | 2018-10-05 |
| Completed | Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers NASH - Nonalcoholic Steatohepatitis | Phase 1 | 2018-07-19 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alco Non-Alcoholic Steatohepatitis | Phase 2 | 2018-04-25 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Primary Biliary Cholangitis | Phase 2 | 2017-12-27 |
| Completed | A Study of EDP-938 in Healthy Subjects RSV Infection | Phase 1 | 2017-12-07 |
| Completed | Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers NASH - Nonalcoholic Steatohepatitis | Phase 1 | 2017-07-11 |
| Completed | A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Voluntee NASH | Phase 1 | 2017-06-14 |
| Completed | Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. NASH | Phase 1 | 2017-05-11 |
| Completed | A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD Presumptive NAFLD | Phase 1 | 2016-09-01 |
| Completed | EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients Hepatitis C | Phase 1 | 2016-01-10 |
| Completed | Two-way Interaction Between Alisporivir and EDP239 Hepatitis C Virus | Phase 1 | 2014-08-01 |
| Terminated | Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788 Healthy | Phase 1 | 2014-08-01 |
| Completed | Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788 Safety in Normal Volunteers | Phase 1 | 2014-01-01 |
| Completed | Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects Hepatitis C | Phase 1 | 2013-06-01 |
| Completed | Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers MRSA, SSTI | Phase 1 | 2008-11-01 |
| Unknown | Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia Community Acquired Pneumonia | Phase 2 | 2005-12-01 |
| Completed | Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunt Skin and Soft Tissue Infections, Methicillin-resistant Staphylococcus Aureus | Phase 1 | — |